Pancreatic beta cell survival and signaling pathways: Effects of type 1 diabetes-associated genetic variants

16Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Type 1 diabetes (T1D) is a complex autoimmune disease in which pancreatic beta cells are specifically destroyed by the immune system. The disease has an important genetic component and more than 50 loci across the genome have been associated with risk of developing T1D. The molecular mechanisms by which these putative T1D candidate genes modulate disease risk, however, remain poorly characterized and little is known about their effects in pancreatic beta cells. Functional studies in in vitro models of pancreatic beta cells, based on techniques to inhibit or overexpress T1D candidate genes, allow the functional characterization of several T1D candidate genes. This requires a multistage procedure comprising two major steps, namely accurate selection of genes of potential interest and then in vitro and/or in vivo mechanistic approaches to characterize their role in pancreatic beta cell dysfunction and death in T1D. This chapter details the methods and settings used by our groups to characterize the role of T1D candidate genes on pancreatic beta cell survival and signaling pathways, with particular focus on potentially relevant pathways in the pathogenesis of T1D, i.e., inflammation and innate immune responses, apoptosis, beta cell metabolism and function.

Cite

CITATION STYLE

APA

Santin, I., Dos Santos, R. S., & Eizirik, D. L. (2016). Pancreatic beta cell survival and signaling pathways: Effects of type 1 diabetes-associated genetic variants. In Methods in Molecular Biology (Vol. 1433, pp. 21–54). Humana Press Inc. https://doi.org/10.1007/7651_2015_291

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free